Murphy Polly A.

CIK 00018292482 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001829248

Recent Transactions

28 trades

Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-06-20−29,600→ 0 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-06-20+29,600→ 29,600 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-06-20+29,600→ 86,045 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-06-20+41,200→ 41,200 total
Gift
Celcuity Inc.$CELC
Stock Option (right to buy)
2025-05-28+8,153→ 8,153 total
Gift
Celcuity Inc.$CELC
Stock Option (right to buy)
2025-05-28−8,153→ 0 total
Award
Celcuity Inc.$CELC
Stock Option (right to buy)
2025-05-19+14,048→ 14,048 total
Gift
Celcuity Inc.$CELC
Stock Option (right to buy)
2024-06-24−16,300→ 0 total
Gift
Celcuity Inc.$CELC
Stock Option (right to buy)
2024-06-24+11,645→ 11,645 total
Gift
Celcuity Inc.$CELC
Stock Option (right to buy)
2024-06-24−11,645→ 0 total
Gift
Celcuity Inc.$CELC
Stock Option (right to buy)
2024-06-24+16,300→ 16,300 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-06-21+41,200→ 41,200 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-06-21+29,600→ 29,600 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-06-16+33,150→ 56,445 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-06-16−33,150→ 0 total
Award
Celcuity Inc.$CELC
Stock Option (right to buy)
2024-06-04+8,153→ 8,153 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-06-16+46,750→ 46,750 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-06-16+33,150→ 33,150 total
Award
Celcuity Inc.$CELC
Stock Option (right to buy)
2023-05-15+11,645→ 11,645 total
Purchase
Celcuity Inc.$CELC
Common Stock
2022-11-22$9.68/sh+5,000→ 5,000 total
Award
Celcuity Inc.$CELC
Stock Option (right to buy)
2022-09-12+10,000→ 10,000 total
Award
Celcuity Inc.$CELC
Stock Option (right to buy)
2022-09-12+16,300→ 16,300 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-06-17+61,264→ 61,264 total
Purchase
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2021-12-20$8.57/sh+12,000→ 23,295 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2021-06-18+34,025→ 34,025 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Series D-1 Convertible Preferred Stock
2020-11-03−4,173→ 0 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Series D Convertible Preferred Stock
2020-11-03−7,122→ 0 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2020-11-03+11,295→ 11,295 total

Companies

Recent Filings

Address

225 FRANKLIN STREET SUITE 2100

BOSTON, MA, 02110

View on SEC.gov